ChulaCov19 mRNA vaccine
ChulaCov19 mRNA vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
The ChulaCov19 vaccine is mRNA-based and was developed in Thailand’s Chulalongkorn University in collaboration with the University of Pennsylvania in the US. Pre-clinical studies in mice and monkeys showed evidence that the vaccine facilitates an impressive generation of neutralizing antibodies. The next phase of this study is for phase I and II clinical trials (NCT04566276) beginning in January 2021.
| Trade Name | ChulaCov19 mRNA vaccine |
| Generic | ChulaCov19 mRNA vaccine |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here ChulaCov19 mRNA vaccine
